NDC 51808-210

Dextran 75

Dextran 75

Dextran 75 is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Anazaohealth Corporation. The primary component is Dextran 75.

Product ID51808-210_29c1fd45-7d77-4882-9e73-8a66742be742
NDC51808-210
Product TypeHuman Prescription Drug
Proprietary NameDextran 75
Generic NameDextran 75
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2012-07-01
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameAnazaoHealth Corporation
Substance NameDEXTRAN 75
Active Ingredient Strength10 mg/1
Pharm ClassesPlasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 51808-210-01

1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 KIT (51808-210-01)
Marketing Start Date2012-07-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51808-210-01 [51808021001]

Dextran 75 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryUnapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-07-01
Inactivation Date2019-11-27

Drug Details

Active Ingredients

IngredientStrength
DEXTRAN 7510 mg/1

OpenFDA Data

SPL SET ID:a71129ae-8266-4064-a3f5-6f2897e62981
Manufacturer
UNII

Pharmacological Class

  • Plasma Volume Expander [EPC]
  • Increased Intravascular Volume [PE]
  • Osmotic Activity [MoA]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.